Long-Term Effects of Trazodone Use
Trazodone at 100 mg nightly carries significant long-term risks that outweigh its limited benefits, particularly daytime somnolence (23% vs 8% placebo), dizziness, and orthostatic hypotension, with rare but serious risks including priapism and cardiac effects. In your specific clinical scenario—combining trazodone with sertraline 100 mg in a patient with unstable anxiety—the risk of serotonin syndrome becomes a critical additional concern.
Common Long-Term Adverse Effects
The most prevalent long-term effects of trazodone include:
Daytime somnolence/sedation: This is the most common adverse effect, occurring in approximately 23% of patients versus 8% on placebo 1. This sedation persists with chronic use and significantly increases fall risk, particularly concerning given your patient's depression and anxiety.
Orthostatic hypotension: A persistent cardiovascular effect that compounds fall risk 2. This becomes more problematic with long-term use as patients may not develop tolerance to this effect.
Dizziness: Occurs frequently and contributes to functional impairment 1.
Serious Long-Term Risks
Cardiac Effects
Trazodone causes dose-dependent moderate QTc prolongation with associated risk of ventricular arrhythmias 2. This is a cumulative concern with chronic use that requires monitoring, especially when combined with other QTc-prolonging medications.
Priapism
Though rare, priapism is a well-documented serious adverse effect that can occur at any point during treatment 3. In one study, 5 of 74 male patients discontinued trazodone specifically due to priapism 3.
Cognitive and Functional Impairment
Long-term sedation leads to:
- Increased risk of falls and fractures
- Impaired daytime functioning
- Potential worsening of depressive symptoms due to sedation-related functional decline
Critical Drug Interaction: Serotonin Syndrome Risk
In your patient taking sertraline 100 mg with unstable anxiety, adding trazodone creates substantial risk for serotonin syndrome 4, 5, 6. Multiple case reports document serotonin syndrome when trazodone is combined with SSRIs:
- One case specifically describes manic switching in a patient stable on sertraline after trazodone addition 5
- Another documents serotonin syndrome within hours of trazodone 100 mg (your exact dose) when combined with serotonergic agents 6
- A 2024 case report details serotonin syndrome from rapid titration of sertraline and trazodone together 4
The mechanism involves trazodone's serotonin reuptake inhibition and 5-HT1A partial agonism combining with sertraline's SSRI effects, creating excessive serotoninergic activity.
Efficacy Concerns
The American Academy of Sleep Medicine guideline explicitly states that trazodone 50 mg showed no clinically significant efficacy for insomnia 7. At 100 mg, while sleep improvements occur, they remain modest:
- Sleep latency reduced by only 10.2 minutes (below clinical significance threshold)
- Total sleep time increased by 21.8 minutes (clinically insignificant)
- 75% of patients experienced adverse events versus 65.4% on placebo 7
The task force concluded that "harms potentially outweigh benefits" despite widespread clinical use 7.
Long-Term Safety Profile Compared to Alternatives
Trazodone shows higher incidence of somnolence than bupropion, fluoxetine, mirtazapine, paroxetine, or venlafaxine 1. For your patient already on sertraline with unstable anxiety, optimizing the SSRI dose or adding cognitive-behavioral therapy for insomnia would be safer than adding trazodone.
Specific Recommendations for Your Clinical Scenario
Do not add trazodone 100 mg to this patient's regimen. Instead:
Optimize sertraline first: The patient recently increased to 100 mg—allow 6-8 weeks for full therapeutic effect on both depression and anxiety before adding agents 1
Address anxiety directly: The "unstable anxiety" suggests inadequate SSRI response. Consider:
- Further sertraline titration (up to 200 mg is FDA-approved)
- Adding evidence-based psychotherapy
- Short-term benzodiazepine taper if severe
For persistent insomnia after SSRI optimization: Consider alternatives with better safety profiles:
- Cognitive-behavioral therapy for insomnia (CBT-I) as first-line
- If pharmacotherapy needed, consider agents without serotonergic effects to avoid drug interactions
Monitoring If Trazodone Is Unavoidable
If trazodone must be used despite these concerns:
- Start at 25-50 mg, not 100 mg, to minimize serotonin syndrome risk
- Monitor closely for serotonin syndrome symptoms: agitation, diaphoresis, myoclonus, tremor, altered mental status, hyperthermia 4, 6
- Assess orthostatic vital signs regularly
- Screen for falls and functional impairment
- Consider baseline and follow-up ECG for QTc monitoring 2
- Counsel male patients about priapism risk
Key Pitfall to Avoid
The most common error is viewing trazodone as "safe" because it's widely prescribed off-label for insomnia. The evidence shows limited efficacy with substantial adverse effects, and the combination with sertraline specifically increases serious drug interaction risk 7, 4, 5, 6. The perception of safety does not match the evidence base.